Valvular heart disease is an important source of cardiovascular morbidity and mortality.
Current prosthetic valve replacement options, such as bioprosthetic and mechanical heart …

The current clinical solutions, including mechanical and bioprosthetic valves for valvular
heart diseases, are plagued by coagulation, calcification, nondurability, and the inability to …

The development of a novel artificial heart valve with outstanding durability and safety has
remained a challenge since the first mechanical heart valve entered the market 65 years …

Heart valve replacement is a common surgical procedure in treating heart conditions such
as stenosis or valvular insufficiency. The use of biomaterials in the manufacture of these …

Expanded polytetrafluoroethylene (ePTFE) is promising in biomedical fields such as
covered stents and plastic surgery owing to its excellent biocompatibility and mechanical …

The polymeric heart valves have attracted considerable attention for treating valvular heart
diseases with favorable biocompatibility, stability and adjustable mechanical properties …

Interfaces within biological tissues not only connect different regions but also contribute to
the overall functionality of the tissue. This is especially true in the case of the aortic heart …

Valvular heart diseases (VHDs) have become one of the most prevalent heart diseases
worldwide, and prosthetic valve replacement is one of the effective treatments. With the fast …

Porous structures with light weight and high mechanical performance exist widely in the
tissues of animals and plants. Biomimetic materials with those porous structures have been …

Transcatheter aortic valve replacement (TAVR) has the advantages of less trauma and faster
postoperative recovery, which has brought the possibility to the elderly patient with valvular …